Relevant conflicts of interest/financial disclosures: A.I.T. has held consultancies with Medtronic, St. Jude Medical, and Boston Scientific, has served on the advisory board of St. Jude Medical, has received honoraria from Medtronic and the Parkinson's Disease Foundation, and has been awarded grants from Medtronic, GlaxoSmithKline, and the National Parkinson Foundation; D.W. has served on the advisory board of Teva Pharmaceuticals and has received honoraria from The Michael J. Fox Foundation for Parkinson's Research; R.P. has held consultancies with GE Healthcare and Elan Pharmaceuticals, has served on the advisory boards of Pfizer and Janssen Alzheimer Immunotherapy, has been awarded grants from the National Institutes of Health (P50 AG016574 and U01 AG006786), and has received royalties from Oxford University Press; C.H.A. has held consultancies with Merck Serono and Teva Pharmaceuticals; K.M. has been awarded grants from the National Institutes of Health (NS36630 and RR024156); D.B. has received honoraria from Merck Serono and The Michael J. Fox Foundation for Parkinson's Research and has received royalties from Henry Stewart Talks; R.B. has held consultancies with Oxford Biomedica, has served on the advisory board of Teva Lundbeck, has received honoraria from GlaxoSmithKline, has been awarded grants from Parkinson's UK, the European Union FP7 program, the Child Health and Development Institute, and The Michael J. Fox Foundation for Parkinson's Research, has been employed by the University of Cambridge, has received royalties from Wiley and Cambridge University Press, and has received monetary compensation from Springer for editorial work for the Journal of Neurology; and M.E. has held a consultancy with Merck Serono, has served on the advisory board of Merck Serono, has received honoraria from Merck Serono, and has received a clinical study grant from Teva Lundbeck.
Article first published online: 24 JAN 2012
Copyright © 2012 Movement Disorder Society
Volume 27, Issue 3, pages 349–356, March 2012
How to Cite
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams-Gray, C. H., Aarsland, D., Kulisevsky, J., Rodriguez-Oroz, M. C., Burn, D. J., Barker, R. A. and Emre, M. (2012), Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov. Disord., 27: 349–356. doi: 10.1002/mds.24893
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 12 MAR 2012
- Article first published online: 24 JAN 2012
- Manuscript Accepted: 21 NOV 2011
- Manuscript Revised: 18 NOV 2011
- Manuscript Received: 12 SEP 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.